Bibliometric Analysis and Systemic Review of Cantharidin Research Worldwide


Cite item

Full Text

Abstract

Background:Cantharidin (CTD), a natural toxic compound from blister beetle Mylabris, has been used for cancer treatment for millenary. CTD and its analogs have become mainstream adjuvant drugs with radiotherapy and chemotherapy in clinical applications. However, the detailed pharmacology mechanism of CTD was not fully elucidated.

Methods:Publications of CTD were collected from the Web of Science Core Collection database from 1991 to 2023 using CiteSpace, VOSviewer, and Scimago Graphica software.

Results:A total of 1,611 publications of CTD were mainly published in China and the United States. The University of Newcastle has published the most researches. Mcclusey, Adam, Sakoff, Jennette, and Zhang, Yalin had the most CTD publications with higher H. Notably, CTD researches were mainly published in Bioorganic & Medicinal Chemistry Letters and the Journal of Biological Chemistry. Cluster profile results revealed that protein phosphatase 2A (PP2A), human gallbladder carcinoma, Aidi injection, and cell apoptosis were the hotspots. Concentration on the pharmacology function of PP2A subunit regulation, hepatotoxicity, nephrotoxicity, and cardiotoxicity mechanism should be strengthened in the future.

Conclusion:Bibliometric analysis combined with a systemic review of CTD research first revealed that PP2A and CTD analogs were the knowledge base of CTD, and PP2A subunit regulation and toxic mechanism could be the frontiers of CTD.

About the authors

Tianmu He

School of Basic Medicine,, Zunyi Medical University

Email: info@benthamscience.net

Cancan Duan

School of Pharmacy and Key Laboratory of Basic Pharmacology Ministry Education and Joint International Research Laboratory of Ethnomedicine, Ministry of Education, Zunyi Medical University

Email: info@benthamscience.net

Wenzhong Feng

School of Pharmacy and Key Laboratory of Basic Pharmacology Ministry Education and Joint International Research Laboratory of Ethnomedicine, Ministry of Education, Zunyi Medical University

Email: info@benthamscience.net

Jingwen Ao

School of Pharmacy and Key Laboratory of Basic Pharmacology Ministry Education and Joint International Research Laboratory of Ethnomedicine, Ministry of Education, Zunyi Medical University

Email: info@benthamscience.net

Dingyang Lu

School of Pharmacy and Key Laboratory of Basic Pharmacology Ministry Education and Joint International Research Laboratory of Ethnomedicine, Ministry of Education,, Zunyi Medical University

Email: info@benthamscience.net

Xiaofei Li

School of Basic Medicine,, Zunyi Medical University

Author for correspondence.
Email: info@benthamscience.net

Jianyong Zhang

School of Pharmacy and Key Laboratory of Basic Pharmacology Ministry Education and Joint International Research Laboratory of Ethnomedicine, Ministry of Education,, Zunyi Medical University

Author for correspondence.
Email: info@benthamscience.net

References

  1. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2018, 68(6), 394-424. doi: 10.3322/caac.21492 PMID: 30207593
  2. Lyman, G.H.; Abella, E.; Pettengell, R. Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review. Crit. Rev. Oncol. Hematol., 2014, 90(3), 190-199. doi: 10.1016/j.critrevonc.2013.12.006 PMID: 24434034
  3. Atanasov, A.G.; Zotchev, S.B.; Dirsch, V.M.; Supuran, C.T. Natural products in drug discovery: Advances and opportunities. Nat. Rev. Drug Discov., 2021, 20(3), 200-216. doi: 10.1038/s41573-020-00114-z PMID: 33510482
  4. Mignani, S.; Rodrigues, J.; Tomas, H.; Zablocka, M.; Shi, X.; Caminade, A.M.; Majoral, J.P. Dendrimers in combination with natural products and analogues as anti-cancer agents. Chem. Soc. Rev., 2018, 47(2), 514-532. doi: 10.1039/C7CS00550D PMID: 29154385
  5. Wang, G.; Dong, J.; Deng, L. Overview of Cantharidin and its Analogues. Curr. Med. Chem., 2018, 25(17), 2034-2044. doi: 10.2174/0929867324666170414165253 PMID: 28413963
  6. Wang, G.S. Medical uses of mylabris in ancient China and recent studies. J. Ethnopharmacol., 1989, 26(2), 147-162. doi: 10.1016/0378-8741(89)90062-7 PMID: 2689797
  7. Li, Y.M.; Casida, J.E. Cantharidin-binding protein: identification as protein phosphatase 2A. Proc. Natl. Acad. Sci. USA, 1992, 89(24), 11867-11870. doi: 10.1073/pnas.89.24.11867 PMID: 1334551
  8. Xiao, Z.; Wang, C.; Zhou, R.; Hu, S.; Yi, N.; Feng, J.; Zhou, M.; Liu, S.; Chen, L.; Ding, J.; Gong, Q.; Tang, F.; Li, X. Can Aidi injection improve overall survival in patients with non-small cell lung cancer? A systematic review and meta-analysis of 25 randomized controlled trials. Complement. Ther. Med., 2018, 37, 50-60. doi: 10.1016/j.ctim.2018.01.011 PMID: 29609937
  9. He, T.M.; Liu, J.X.; Duan, C.C.; Li, X.F.; Zhang, J.Y. Effective material basis and mechanism analysis of compound banmao capsule against tumors using integrative network pharmacology and molecular docking. Evid. Based Complement. Alternat. Med., 2021, 2021, 1-21. doi: 10.1155/2021/6653460 PMID: 34055017
  10. Liu, M.; Xu, C.; Sun, Y. Efficacy and safety of sodium cantharidinate and vitamin B6 injection for the treatment of digestive system neoplasms: A meta-analysis of randomized controlled trials. Drug Des. Devel. Ther., 2018, 13, 183-203. doi: 10.2147/DDDT.S190674 PMID: 30643386
  11. Till, J.S.; Majmudar, B.N. Cantharidin poisoning. South. Med. J., 1981, 74(4), 444-447. doi: 10.1097/00007611-198104000-00019 PMID: 7221663
  12. Zhang, Y.; Zhou, X.; Zhang, J.; Guan, C.; Liu, L. Cantharides poisoning: A retrospective analysis from 1996 to 2016 in China. Regul. Toxicol. Pharmacol., 2018, 96, 142-145. doi: 10.1016/j.yrtph.2018.05.007 PMID: 29753762
  13. Zhang, Y.Y.; Yu, Y.L.; Zhang, J.; Guan, C.H.; Ren, L.; Liu, L. Research progress on multiple organ damage and mechanism of cantharidin poisoning. Fa Yi Xue Za Zhi, 2020, 36(4), 545-548. PMID: 33047541
  14. An, P.; Lu, D.; Zhang, L.; Lan, H.; Yang, H.; Ge, G.; Liu, W.; Shen, W.; Ding, X.; Tang, D.; Zhang, W.; Luan, X.; Cheng, H.; Zhang, H. Synergistic antitumor effects of compound-composed optimal formula from Aidi injection on hepatocellular carcinoma and colorectal cancer. Phytomedicine, 2022, 103, 154231. doi: 10.1016/j.phymed.2022.154231 PMID: 35691079
  15. Schöpe, P.C.; Zinnow, V.; Ishfaq, M.A.; Smith, J.; Herrmann, P.; Shoemaker, R.H.; Walther, W.; Stein, U. Cantharidin and its analogue norcantharidin inhibit metastasis—inducing genes S100A4 and MACC1. Int. J. Mol. Sci., 2023, 24(2), 1179. doi: 10.3390/ijms24021179 PMID: 36674695
  16. Du, L.; Feng, Y.; He, Z.; Huang, L.; Wang, Q.; Wen, C.; Zhang, Y. Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells. Acta Pharmacol. Sin., 2022, 43(6), 1521-1533. doi: 10.1038/s41401-021-00773-7 PMID: 34552214
  17. Li, S.; Wu, X.; Fan, G.; Du, K.; Deng, L. Exploring cantharidin and its analogues as anticancer agents: A review. Curr. Med. Chem., 2022. PMID: 36330637
  18. Ma, L.; Sun, X.; Ji, W.; Zhang, B.; Li, J.; Fu, W.; Zhang, X.; Qian, W.; Sheng, E.; Zhu, D. Supramolecular self-assembled AIE molecules are used in the search for target proteins in norcantharidin. Anal. Chim. Acta, 2023, 1239, 340642. doi: 10.1016/j.aca.2022.340642 PMID: 36628744
  19. Zhai, B.T.; Sun, J.; Shi, Y.J.; Zhang, X.F.; Zou, J.B.; Cheng, J.X.; Fan, Y.; Guo, D.Y.; Tian, H. Review targeted drug delivery systems for norcantharidin in cancer therapy. J. Nanobiotechnology, 2022, 20(1), 509. doi: 10.1186/s12951-022-01703-3 PMID: 36463199
  20. Liu, Q.; Sun, H.; Li, X.; Sheng, H.; Zhu, L. Strategies for solubility and bioavailability enhancement and toxicity reduction of norcantharidin. Molecules, 2022, 27(22), 7740. doi: 10.3390/molecules27227740 PMID: 36431851
  21. Chen, C. Searching for intellectual turning points: Progressive knowledge domain visualization. Proc. Natl. Acad. Sci. USA, 2004, 101(S1), 5303-5310. doi: 10.1073/pnas.0307513100 PMID: 14724295
  22. Dong, Q.; Liang, Q.; Chen, Y.; Li, J.; Lu, L.; Huang, X.; Zhou, Q. Bibliometric and visual analysis of vascular calcification research. Front. Pharmacol., 2021, 12, 690392. doi: 10.3389/fphar.2021.690392 PMID: 34335257
  23. He, T.; Ao, J.; Duan, C.; Yan, R.; Li, X.; Liu, L.; Zhang, J.; Li, X. Bibliometric and visual analysis of nephrotoxicity research worldwide. Front. Pharmacol., 2022, 13, 940791. doi: 10.3389/fphar.2022.940791 PMID: 36188597
  24. Chen, C. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. J. Am. Soc. Inf. Sci. Technol., 2006, 57(3), 359-377. doi: 10.1002/asi.20317
  25. van Eck, N.J.; Ludo, W. VOS: A new method for visualizing similarities between objects. In: Advances in Data Analysis; , 2007; pp. 299-306.
  26. Li, W.; Xie, L.; Chen, Z.; Zhu, Y.; Sun, Y.; Miao, Y.; Xu, Z.; Han, X. Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis. Cancer Sci., 2010, 101(5), 1226-1233. doi: 10.1111/j.1349-7006.2010.01523.x PMID: 20331621
  27. Liu, X.H.; Blazsek, I.; Comisso, M.; Legras, S.; Marion, S.; Quittet, P.; Anjo, A.; Wang, G.S.; Misset, J.L. Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells. Eur. J. Cancer, 1995, 31(6), 953-963. doi: 10.1016/0959-8049(95)00050-X PMID: 7646929
  28. Chen, Y.N.; Chen, J.C.; Yin, S.C.; Wang, G.S.; Tsauer, W.; Hsu, S.F.; Hsu, S.L. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. Int. J. Cancer, 2002, 100(2), 158-165. doi: 10.1002/ijc.10479 PMID: 12115564
  29. Kok, S.H.; Cheng, S.J.; Hong, C.Y.; Lee, J.J.; Lin, S.K.; Kuo, Y.S.; Chiang, C.P.; Kuo, M.Y.P. Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio. Cancer Lett., 2005, 217(1), 43-52. doi: 10.1016/j.canlet.2004.07.045 PMID: 15596295
  30. Huang, W.W.; Ko, S.W.; Tsai, H.Y.; Chung, J.G.; Chiang, J.H.; Chen, K.T.; Chen, Y.C.; Chen, H.Y.; Chen, Y.F.; Yang, J.S. Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways. Int. J. Oncol., 2011, 38(4), 1067-1073. PMID: 21271215
  31. Shirasu, K.; Nakajima, H.; Rajasekhar, V.K.; Dixon, R.A.; Lamb, C. Salicylic acid potentiates an agonist-dependent gain control that amplifies pathogen signals in the activation of defense mechanisms. Plant Cell, 1997, 9(2), 261-270. PMID: 9061956
  32. Morris, T.; Stables, M.; Hobbs, A.; de Souza, P.; Colville-Nash, P.; Warner, T.; Newson, J.; Bellingan, G.; Gilroy, D.W. Effects of low-dose aspirin on acute inflammatory responses in humans. J. Immunol., 2009, 183(3), 2089-2096. doi: 10.4049/jimmunol.0900477 PMID: 19597002
  33. Harvey, A.L.; Edrada-Ebel, R.; Quinn, R.J. The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov., 2015, 14(2), 111-129. doi: 10.1038/nrd4510 PMID: 25614221
  34. Newman, D.J. Modern traditional Chinese medicine: Identifying, defining and usage of TCM components. Adv. Pharmacol., 2020, 87, 113-158. doi: 10.1016/bs.apha.2019.07.001 PMID: 32089231
  35. Wei, G.; Wang, Y.; Yang, G.; Wang, Y.; Ju, R. Recent progress in nanomedicine for enhanced cancer chemotherapy. Theranostics, 2021, 11(13), 6370-6392. doi: 10.7150/thno.57828 PMID: 33995663
  36. Nakatani, T.; Konishi, T.; Miyahara, K.; Noda, N. Three novel cantharidin-related compounds from the Chinese blister beetle, Mylabris phalerata Pall. Chem. Pharm. Bull. (Tokyo), 2004, 52(7), 807-809. doi: 10.1248/cpb.52.807 PMID: 15256700
  37. Yang, M.; Shen, C.; Zhu, S.J. Chinese patent medicine Aidi injection for cancer care: An overview of systematic reviews and metaanalyses. J Ethnopharmacol, 2022, 282, 114656.
  38. Shou, L.M.; Zhang, Q.Y.; Li, W.; Xie, X.; Chen, K.; Lian, L.; Li, Z.Y.; Gong, F.R.; Dai, K.S.; Mao, Y.X.; Tao, M. Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin. Oncol. Rep., 2013, 30(3), 1059-1066. doi: 10.3892/or.2013.2601 PMID: 23835679
  39. McCluskey, A.; Ackland, S.P.; Bowyer, M.C.; Baldwin, M.L.; Garner, J.; Walkom, C.C.; Sakoff, J.A. Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines. Bioorg. Chem., 2003, 31(1), 68-79. doi: 10.1016/S0045-2068(02)00524-2 PMID: 12697169
  40. Hart, M.E.; Chamberlin, A.R.; Walkom, C.; Sakoff, J.A.; McCluskey, A. Modified norcantharidins. Bioorg. Med. Chem. Lett., 2004, 14(8), 1969-1973. doi: 10.1016/j.bmcl.2004.01.093 PMID: 15050639
  41. Hill, T.A.; Stewart, S.G.; Sauer, B.; Gilbert, J.; Ackland, S.P.; Sakoff, J.A.; McCluskey, A. Heterocyclic substituted cantharidin and norcantharidin analogues—synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity. Bioorg. Med. Chem. Lett., 2007, 17(12), 3392-3397. doi: 10.1016/j.bmcl.2007.03.093 PMID: 17451951
  42. Bajsa, J.; McCluskey, A.; Gordon, C.P.; Stewart, S.G.; Hill, T.A.; Sahu, R.; Duke, S.O.; Tekwani, B.L. The antiplasmodial activity of norcantharidin analogs. Bioorg. Med. Chem. Lett., 2010, 20(22), 6688-6695. doi: 10.1016/j.bmcl.2010.09.004 PMID: 20888768
  43. Campbell, B.E.; Tarleton, M.; Gordon, C.P.; Sakoff, J.A.; Gilbert, J.; McCluskey, A.; Gasser, R.B. Norcantharidin analogues with nematocidal activity in Haemonchus contortus. Bioorg. Med. Chem. Lett., 2011, 21(11), 3277-3281. doi: 10.1016/j.bmcl.2011.04.031 PMID: 21536433
  44. He, T.; Wang, Q.; Ao, J.; Chen, K.; Li, X.; Zhang, J.; Duan, C. Endoplasmic reticulum stress contributes to autophagy and apoptosis in cantharidin-induced nephrotoxicity. Food Chem. Toxicol., 2022, 163, 112986. doi: 10.1016/j.fct.2022.112986 PMID: 35398186
  45. He, T.; Liu, J.; Wang, X.; Duan, C.; Li, X.; Zhang, J. Analysis of cantharidin-induced nephrotoxicity in HK-2 cells using untargeted metabolomics and an integrative network pharmacology analysis. Food Chem. Toxicol., 2020, 146, 111845. doi: 10.1016/j.fct.2020.111845 PMID: 33152469
  46. Xiao, Z.; Jiang, Y.; Chen, X.F.; Wang, C.Q.; Xu, W.; Liu, Y.; Hu, S.S.; Huang, X.R.; Shan, L.J.; Tang, Y.H.; Yang, Y.B.; Feng, J.H.; Xiao, X.; Li, X.F. The Hepatorenal Toxicity and Tumor Response of Chemotherapy With or Without Aidi Injection in Advanced Lung Cancer: A Meta-Analysis of 80 Randomized Controlled Trials. Clin. Ther., 2020, 42(3), 515-543.e31. doi: 10.1016/j.clinthera.2020.01.011 PMID: 32088021
  47. Zhou, Q.; Wu, F.; Zhao, M.; Yang, M. Bibliometric Evaluation of 2012–2020 Publications on Ferroptosis in Cancer Treatment. Front. Cell Dev. Biol., 2022, 9, 793347. doi: 10.3389/fcell.2021.793347 PMID: 35118077
  48. Wlodarchak, N.; Xing, Y. PP2A as a master regulator of the cell cycle. Crit. Rev. Biochem. Mol. Biol., 2016, 51(3), 162-184. doi: 10.3109/10409238.2016.1143913 PMID: 26906453
  49. Honkanen, R.E. Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A. FEBS Lett., 1993, 330(3), 283-286. doi: 10.1016/0014-5793(93)80889-3 PMID: 8397101
  50. Liu, D.; Chen, Z. The effects of cantharidin and cantharidin derivates on tumour cells. Anticancer. Agents Med. Chem., 2009, 9(4), 392-396. doi: 10.2174/1871520610909040392 PMID: 19442040
  51. Naz, F.; Wu, Y.; Zhang, N.; Yang, Z.; Yu, C. Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways. Molecules, 2020, 25(14), 3279. doi: 10.3390/molecules25143279 PMID: 32707651
  52. Zhou, J.; Ren, Y.; Tan, L.; Song, X.; Wang, M.; Li, Y.; Cao, Z.; Guo, C. Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years. Biomed. Pharmacother., 2020, 131, 110755. doi: 10.1016/j.biopha.2020.110755 PMID: 33152920
  53. Kim, J.A.; Kim, Y.; Kwon, B.M.; Han, D.C. The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters. J. Biol. Chem., 2013, 288(40), 28713-28726. doi: 10.1074/jbc.M113.488346 PMID: 23983126
  54. Zeng, D.; Xiao, Z.; Xu, Q.; Luo, H.; Wen, L.; Tang, C.; Shan, Y.; Tian, J.; Wei, J.; Li, Y. Norcantharidin protects against renal interstitial fibrosis by suppressing TWEAK-mediated Smad3 phosphorylation. Life Sci., 2020, 260, 118488. doi: 10.1016/j.lfs.2020.118488 PMID: 32979359
  55. Xiao, Z.; Wen, L.; Zeng, D.; Yin, D.; Zhou, X.; Tang, C.; Li, Y. Protein Phosphatase 2A Inhibiting β-Catenin Phosphorylation Contributes Critically to the Anti-renal Interstitial Fibrotic Effect of Norcantharidin. Inflammation, 2020, 43(3), 878-891. doi: 10.1007/s10753-019-01173-0 PMID: 31940108
  56. Li, Y.M.; Mackintosh, C.; Casida, J.E. Protein phosphatase 2A and its 3Hcantharidin/3Hendothall thioanhydride binding site. Biochem. Pharmacol., 1993, 46(8), 1435-1443. doi: 10.1016/0006-2952(93)90109-A PMID: 8240393
  57. Zhou, H.; Xu, J.; Wang, S.; Peng, J. Role of cantharidin in the activation of IKKα/IκBα/NF κB pathway by inhibiting PP2A activity in cholangiocarcinoma cell lines. Mol. Med. Rep., 2018, 17(6), 7672-7682. doi: 10.3892/mmr.2018.8860 PMID: 29620225
  58. Shan, H.; Cai, Y.; Liu, Y.; Zeng, W.; Chen, H.; Fan, B.; Liu, X.; Xu, Z.; Wang, B.; Xian, L. Cytotoxicity of cantharidin analogues targeting protein phosphatase 2A. Anticancer Drugs, 2006, 17(8), 905-911. doi: 10.1097/01.cad.0000217428.90325.35 PMID: 16940800
  59. Wang, C.Q.; Zheng, X.T.; Chen, X.F.; Jiang, H.; Huang, J.; Jiang, Y.; Hu, S.S.; Huang, X.R.; Liu, S.Y.; Gong, Q.H.; Feng, J.H.; Xiao, X.; Li, X.F.; Xiao, Z. The Optimal Adjuvant Strategy of Aidi Injection With Gemcitabine and Cisplatin in Advanced Non–small Cell Lung Cancer: A Meta-analysis of 70 Randomized Controlled Trials. Front. Pharmacol., 2021, 12, 582447. doi: 10.3389/fphar.2021.582447 PMID: 34122057
  60. Nazim, U.; Yin, H.; Park, S.Y. Downregulation of c FLIP and upregulation of DR 5 by cantharidin sensitizes TRAIL mediated apoptosis in prostate cancer cells via autophagy flux. Int. J. Mol. Med., 2020, 46(1), 280-288. doi: 10.3892/ijmm.2020.4566 PMID: 32319535
  61. Prasad, S.B.; Verma, A.K. Cantharidin-mediated ultrastructural and biochemical changes in mitochondria lead to apoptosis and necrosis in murine Dalton’s lymphoma. Microsc. Microanal., 2013, 19(6), 1377-1394. doi: 10.1017/S143192761301324X PMID: 24029497
  62. Yu, Z.; Li, L.; Wang, C.; He, H.; Liu, G.; Ma, H.; Pang, L.; Jiang, M.; Lu, Q.; Li, P.; Qi, H. Cantharidin Induces Apoptosis and Promotes Differentiation of AML Cells Through Nuclear Receptor Nur77-Mediated Signaling Pathway. Front. Pharmacol., 2020, 11, 1321. doi: 10.3389/fphar.2020.01321 PMID: 32982739
  63. Fan, Y.Z.; Zhao, Z.M.; Fu, J.Y.; Chen, C.Q.; Sun, W. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo. Hepatobiliary Pancreat. Dis. Int., 2010, 9(4), 414-422. PMID: 20688607
  64. Zhang, J.T.; Sun, W.; Zhang, W.Z.; Ge, C.Y.; Liu, Z.Y.; Zhao, Z.M.; Lu, X.S.; Fan, Y.Z. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway. BMC Cancer, 2014, 14(1), 193. doi: 10.1186/1471-2407-14-193 PMID: 24628713
  65. Fan, Y.Z.; Fu, J.Y.; Zhao, Z.M.; Chen, C.Q. Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells. World J. Gastroenterol., 2005, 11(16), 2431-2437. doi: 10.3748/wjg.v11.i16.2431 PMID: 15832413
  66. Puerto Galvis, C.E.; Vargas Méndez, L.Y.; Kouznetsov, V.V. Cantharidin-based small molecules as potential therapeutic agents. Chem. Biol. Drug Des., 2013, 82(5), 477-499. doi: 10.1111/cbdd.12180 PMID: 23809227
  67. Li, H.; Xia, Z.; Chen, Y.; Yang, F.; Feng, W.; Cai, H.; Mei, Y.; Jiang, Y.; Xu, K.; Feng, D. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in vitro and in vivo. Cell. Physiol. Biochem., 2017, 43(5), 1829-1840. doi: 10.1159/000484069 PMID: 29050003
  68. Pan, Y.; Zheng, Q.; Ni, W.; Wei, Z.; Yu, S.; Jia, Q.; Wang, M.; Wang, A.; Chen, W.; Lu, Y. Breaking Glucose Transporter 1/Pyruvate Kinase M2 Glycolytic Loop Is Required for Cantharidin Inhibition of Metastasis in Highly Metastatic Breast Cancer. Front. Pharmacol., 2019, 10, 590. doi: 10.3389/fphar.2019.00590 PMID: 31178738
  69. Pang, J.; Huang, F.; Zhang, Y.; Wu, Y.; Ge, X.; Li, S.; Li, X. Sodium cantharidate induces Apoptosis in breast cancer cells by regulating energy metabolism via the protein phosphatase 5-p53 axis. Toxicol. Appl. Pharmacol., 2021, 430, 115726. doi: 10.1016/j.taap.2021.115726 PMID: 34537213
  70. Liu, D.; Shi, P.; Yin, X.; Chen, Z.; Zhang, X. Effect of norcantharidin on the human breast cancer Bcap-37 cells. Connect. Tissue Res., 2012, 53(6), 508-512. doi: 10.3109/03008207.2012.694928 PMID: 22606958
  71. Zhang, S.; Yang, Y.; Hua, Y.; Hu, C.; Zhong, Y. NCTD elicits proapoptotic and antiglycolytic effects on colorectal cancer cells via modulation of Fam46c expression and inhibition of ERK1/2 signaling. Mol. Med. Rep., 2020, 22(2), 774-782. doi: 10.3892/mmr.2020.11151 PMID: 32468032
  72. Zhang, J.; Chen, Q.; Wang, L.; Chen, K.; Mu, W.; Duan, C.; Li, X. Study on the mechanism of cantharidin-induced hepatotoxicity in rat using serum and liver metabolomics combined with conventional pathology methods. J. Appl. Toxicol., 2020, 40(9), 1259-1271. doi: 10.1002/jat.3983 PMID: 32468647
  73. Zhou, C.; Qiao, L.; Zhao, L.; Li, Z. Evaluation of the impact of cantharidin on rat CYP enzymes by using a cocktail of probe drugs. Fitoterapia, 2015, 107, 49-53. doi: 10.1016/j.fitote.2015.10.008 PMID: 26498206
  74. Yu, Y.; Zhang, Y.; Zhang, J.; Guan, C.; Liu, L.; Ren, L. Cantharidin-induced acute hepatotoxicity: the role of TNF-α IKK-α Bcl-2, Bax and caspase3. J. Appl. Toxicol., 2020, 40(11), 1526-1533. doi: 10.1002/jat.4003 PMID: 32627230
  75. Liu, F.; Duan, C.; Zhang, J.; Li, X. Cantharidin-induced LO2 cell autophagy and apoptosis via endoplasmic reticulum stress pathway in vitro. J. Appl. Toxicol., 2020, 40(12), 1622-1635. doi: 10.1002/jat.4022 PMID: 32638414
  76. Wu, W.; Su, M.; Li, T.; Wu, K.; Wu, X.; Tang, Z. Cantharidin-induced liver injuries in mice and the protective effect of vitamin C supplementation. Int. Immunopharmacol., 2015, 28(1), 182-187. doi: 10.1016/j.intimp.2015.06.003 PMID: 26071218
  77. Jiang, Z.; Chi, J.; Han, B.; Liu, W. Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma. Carbohydr. Polym., 2017, 174, 282-290. doi: 10.1016/j.carbpol.2017.06.072 PMID: 28821069
  78. Zhu, S.; Long, R.; Song, T.; Zhang, L.; Dai, Y.; Liu, S.; Zhang, P. UPLC-Q-TOF/MS Based Metabolomics Approach to Study the Hepatotoxicity of Cantharidin on Mice. Chem. Res. Toxicol., 2019, 32(11), 2204-2213. doi: 10.1021/acs.chemrestox.9b00233 PMID: 31617706
  79. Liu, F.; Wang, X.; Duan, C.; Zhang, J.; Li, X. Hepatoxicity mechanism of cantharidin-induced liver LO2 cells by LC-MS metabolomics combined traditional approaches. Toxicol. Lett., 2020, 333, 49-61. doi: 10.1016/j.toxlet.2020.07.024
  80. Martinez-Razo, G.; Dominguez-Lopez, M.L.; de la Rosa, J.M. Norcantharidin toxicity profile: an in vivo murine study. Naunyn Schmiedebergs Arch. Pharmacol., 2022. PMID: 36184699
  81. He, T.; Xiong, L.; Zhang, Y.; Yan, R.; Yu, M.; Liu, M.; Liu, L.; Duan, C.; Li, X.; Zhang, J. Mice kidney biometabolic process analysis after cantharidin exposure using widely-targeted metabolomics combined with network pharmacology. Food Chem. Toxicol., 2023, 171, 113541. doi: 10.1016/j.fct.2022.113541 PMID: 36464109
  82. Zhang, Y.; Liu, L.; Ren, L. RNA-sequencing-based transcriptome analysis of cantharidin-induced myocardial injury. J. Appl. Toxicol., 2020, 40(11), 1491-1497. doi: 10.1002/jat.4000 PMID: 32618016
  83. Youyou, Z.; Yalei, Y.; Jie, Z.; Chuhuai, G.; Liang, L.; Liang, R. Molecular biomarkers of cantharidin-induced cardiotoxicity in Sprague-Dawley rats: Troponin T, vascular endothelial growth factor and hypoxia inducible factor-1α. J. Appl. Toxicol., 2020, 40(8), 1153-1161. doi: 10.1002/jat.3974 PMID: 32162354
  84. Lan, H.Y.; An, P.; Liu, Q.P.; Chen, Y.Y.; Yu, Y.Y.; Luan, X.; Tang, J.Y.; Zhang, H. Aidi injection induces apoptosis of hepatocellular carcinoma cells through the mitochondrial pathway. J. Ethnopharmacol., 2021, 274, 114073. doi: 10.1016/j.jep.2021.114073 PMID: 33794335
  85. Li, L.; Zhu, L.; Zhu, J.; Fan, X.; Ye, X. Mechanisms of inhibiting human leukemia cell lines by serum of rats treated with compound banmao capsule. Oncol. Lett., 2017, 14(4), 4092-4098. doi: 10.3892/ol.2017.6688 PMID: 28989536
  86. Huang, X.; Tang, W.; Lin, C.; Sa, Z.; Xu, M.; Liu, J.; Wang, L.; Li, W.; Chen, Y.; Yang, C. Protective mechanism of Astragalus Polysaccharides against Cantharidin-induced liver injury determined in vivo by liquid chromatography/mass spectrometry metabolomics. Basic Clin. Pharmacol. Toxicol., 2021, 129(1), 61-71. doi: 10.1111/bcpt.13585 PMID: 33834601
  87. Gao, H.; Kang, N.; Hu, C.; Zhang, Z.; Xu, Q.; Liu, Y.; Yang, S. Ginsenoside Rb1 exerts anti-inflammatory effects in vitro and in vivo by modulating toll-like receptor 4 dimerization and NF-kB/MAPKs signaling pathways. Phytomedicine, 2020, 69, 153197. doi: 10.1016/j.phymed.2020.153197 PMID: 32146298
  88. Shao, H.; Dong, L.; Feng, Y.; Wang, C.; Tong, H. The protective effect of L-glutamine against acute Cantharidin-induced Cardiotoxicity in the mice. BMC Pharmacol. Toxicol., 2020, 21(1), 71. doi: 10.1186/s40360-020-00449-8 PMID: 33004081

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers